Hangzhou Jiuyuan Genetic Biopharmaceutical (2566 HK)

Analysis

Health Care • China

Hangzhou Jiuyuan Genetic Biopharmaceutical is a biopharmaceutical company specializing in the research, development, manufacturing, and commercialization of biopharmaceutical products and medical devices. The company focuses on therapeutic areas including orthopedics, metabolic diseases, oncology, and hematology, with key products like Guyoudao for bone repair and Jilifen for neutropenia. It was founded in December 1993 and is headquartered in Hangzhou, China.

Refresh

Exchange Announcement • 13 Oct 2026 19:09

Next Day Disclosure Returns

Exchange Announcement • 12 Oct 2026 19:39

Next Day Disclosure Returns

Exchange Announcement • 08 Oct 2026 21:02

Next Day Disclosure Returns

Exchange Announcement • 28 Sep 2026 19:30

Next Day Disclosure Returns

Exchange Announcement • 24 Sep 2026 20:26

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00